ClinConnect ClinConnect Logo
Search / Trial NCT03598478

Tai Chi-muscle Power Training for Primary School Children With Developmental Coordination Disorder

Launched by THE UNIVERSITY OF HONG KONG · Jul 14, 2018

Trial Information

Current as of June 09, 2025

Unknown status

Keywords

ClinConnect Summary

Children with developmental coordination disorder (DCD), who comprise about 6% of the primary school population, display marked movement and balance difficulties. Reduced limits of stability (LOS), the maximum spatial area in which a standing person can lean, in these children is a major concern because it predisposes them to falls and affects their motor development.

The investigator's recent studies demonstrate the underlying causes of impaired LOS in children with DCD to include suboptimal volitional control of the center of gravity (COG) and reduced leg muscle force production speed. T...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 9- to 12-years-old
  • Classified as DCD according to the Diagnostic and Statistical Manual of Mental Disorders V (DSM-5)
  • A percentile score of \< 5th percentile on the MABC-2
  • A total score of \< 55 (for children aged 8 to 9 years 11 months) or \< 57 (for children aged 10 or above) on the DCD questionnaire 2007 (Chinese version)
  • Attending a mainstream primary school (i.e., intelligence level within the normal range)
  • Exclusion Criteria:
  • Any known significant congenital, cognitive, psychiatric (other than comorbid attention deficit hyperactivity disorder \[ADHD\] or autism spectrum disorder \[ASD\]), neurological, sensory, musculoskeletal, or cardiopulmonary disorder that may affect motor performance
  • Receiving active treatment such as physiotherapy
  • Demonstrating excessive disruptive behavior during the assessments
  • Those unable to follow instructions properly

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Shirley Fong, PhD

Principal Investigator

The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials